{"id":"W3122478524","doi":"10.1200/jco.2021.39.3_suppl.8","title":"NRG-GI002: A phase II clinical trial platform using total neoadjuvant therapy (TNT) in locally advanced rectal cancer (LARC)—Pembrolizumab experimental arm (EA) primary results.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre","funders":"National Institutes of Health","keywords":"Medicine; Pembrolizumab; Capecitabine; Colorectal cancer; Total mesorectal excision; Population; Internal medicine; FOLFOX; Clinical endpoint; Neoadjuvant therapy; Randomized controlled trial; Phases of clinical research; Surgery; Oncology; Cancer; Clinical trial; Oxaliplatin; Breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003589289,0.001648139,0.001132974,0.000547232,0.0003630054,0.0008465109,0.000997945,0.001477457,0.006183208],"category_scores_gemma":[0.001800314,0.0004936518,0.001265362,0.0004825649,0.0008944409,0.0006715946,0.0005861192,0.002540691,0.001111036],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007719031,"about_ca_system_score_gemma":0.002578957,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006937949,"about_ca_topic_score_gemma":0.00270467,"domain_scores_codex":[0.9991702,0.0005604143,0.00002677938,0.00008208279,0.00006513279,0.00009542424],"domain_scores_gemma":[0.9991672,0.0001258416,0.0002131013,0.0000987225,0.00005604979,0.0003390628],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8286151,0.06209853,0.004064888,0.001315709,0.0009357123,0.0001721874,0.0001503988,0.00206638,0.03647503,0.0006385539,0.007470405,0.05599704],"study_design_scores_gemma":[0.6412423,0.3478089,0.004221802,0.00004884374,0.0002985785,0.00015521,0.00002697515,0.0007814674,0.002315213,0.0002321337,0.00284895,0.00001971208],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.96535,0.001836302,0.001836657,0.00135212,0.0003272861,0.01847122,0.004928783,0.0003516401,0.005545896],"genre_scores_gemma":[0.9272189,0.001609725,0.01042817,0.002791908,0.0003649863,0.04101387,0.008487562,0.0001109539,0.007973852],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006183208,"threshold_uncertainty_score":0.0206849,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2935761635148743,"score_gpt":0.5580124301005489,"score_spread":0.2644362665856746,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}